3-(3-(Pyridin-3-yl)propyl)-1H-indole

ID: ALA1812653

PubChem CID: 53392060

Max Phase: Preclinical

Molecular Formula: C16H16N2

Molecular Weight: 236.32

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  c1cncc(CCCc2c[nH]c3ccccc23)c1

Standard InChI:  InChI=1S/C16H16N2/c1-2-9-16-15(8-1)14(12-18-16)7-3-5-13-6-4-10-17-11-13/h1-2,4,6,8-12,18H,3,5,7H2

Standard InChI Key:  YBFSGMZRHXSPTL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
    0.9027   -5.6916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9016   -6.5190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6164   -6.9319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6146   -5.2789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3300   -5.6880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3302   -6.5190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1207   -6.7756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6090   -6.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1203   -5.4310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5262   -4.7137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3512   -4.7066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7576   -3.9886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5825   -3.9816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9970   -4.6946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8212   -4.6878    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2284   -3.9693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8054   -3.2561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9825   -3.2664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  8  9  2  0
  9  5  1  0
  4  1  1  0
  9 10  1  0
  5  6  1  0
 10 11  1  0
 11 12  1  0
  2  3  1  0
 12 13  1  0
  3  6  2  0
 13 14  2  0
  1  2  2  0
 14 15  1  0
  5  4  2  0
 15 16  2  0
  6  7  1  0
 16 17  1  0
  7  8  1  0
 17 18  2  0
 18 13  1  0
M  END

Alternative Forms

Associated Targets(non-human)

Tdo2 Tryptophan 2,3-dioxygenase (195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 236.32Molecular Weight (Monoisotopic): 236.1313AlogP: 3.74#Rotatable Bonds: 4
Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.56CX LogP: 3.84CX LogD: 3.83
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.73Np Likeness Score: -0.39

References

1. Dolusić E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R..  (2011)  Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.,  54  (15): [PMID:21726069] [10.1021/jm2006782]

Source